Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Martin Frenzel
MONARCH 1, a Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients With Refractory HR + /HER2 − Metastatic Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Related publications
A Longitudinal Investigation of the Relationships Between Patient-Reported Symptoms and Survival Among Patients With HR+/HER2- Metastatic Breast Cancer (MBC) Treated With Abemaciclib in the Phase 2 Monarch 1 Trial
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Real-World Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis
Scientific Reports
Multidisciplinary
Everolimus-Based Therapy Versus Chemotherapy Among Patients With HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness From a Chart Review Study
International Journal of Breast Cancer
Cancer Research
Oncology
Pharmacology
Emerging Data and Future Directions for CDK4/6 Inhibitor Treatment of Patients With Hormone Receptor Positive HER2-non-amplified Metastatic Breast Cancer
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Phase II Study of Gemcitabine Monotherapy in Breast Cancer Patients Refractory to Anthracycline and Taxane
Cancer Research and Treatment
Cancer Research
Oncology
Phase II Study of Pembrolizumab and Capecitabine for Triple Negative and Hormone Receptor-Positive, HER2−negative Endocrine-Refractory Metastatic Breast Cancer
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
S‐1 Plus Raltitrexed for Refractory Metastatic Colorectal Cancer: A Phase II Trial
Oncologist
Cancer Research
Medicine
Oncology
Phase II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
The Internet Journal of Oncology
